Literature DB >> 27742842

There and Back Again: The Middle Earth of DNA Repair.

Karen E Knudsen1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27742842      PMCID： PMC5223289          DOI： 10.1158/1541-7786.MCR-16-0298

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN： 1541-7786            Impact factor:   5.852


× No keyword cloud information.
  24 in total

1.  Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins.

Authors:  Uday Bhanu Maachani; Tamalee Kramp; Ryan Hanson; Shuping Zhao; Orieta Celiku; Uma Shankavaram; Riccardo Colombo; Natasha J Caplen; Kevin Camphausen; Anita Tandle
Journal:  Mol Cancer Res       Date:  2015-02-26       Impact factor: 5.852

2.  Targeted radiosensitization of ETS fusion-positive prostate cancer through PARP1 inhibition.

Authors:  Sumin Han; J Chad Brenner; Aaron Sabolch; Will Jackson; Corey Speers; Kari Wilder-Romans; Karen E Knudsen; Theodore S Lawrence; Arul M Chinnaiyan; Felix Y Feng
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

3.  Dual roles of PARP-1 promote cancer growth and progression.

Authors:  Matthew J Schiewer; Jonathan F Goodwin; Sumin Han; J Chad Brenner; Michael A Augello; Jeffry L Dean; Fengzhi Liu; Jamie L Planck; Preethi Ravindranathan; Arul M Chinnaiyan; Peter McCue; Leonard G Gomella; Ganesh V Raj; Adam P Dicker; Jonathan R Brody; John M Pascal; Margaret M Centenera; Lisa M Butler; Wayne D Tilley; Felix Y Feng; Karen E Knudsen
Journal:  Cancer Discov       Date:  2012-09-19       Impact factor: 39.397

4.  A synthetic lethal screen reveals enhanced sensitivity to ATR inhibitor treatment in mantle cell lymphoma with ATM loss-of-function.

Authors:  Daniel L Menezes; Jenny Holt; Yan Tang; Jiajia Feng; Paul Barsanti; Yue Pan; Majid Ghoddusi; Wei Zhang; George Thomas; Jocelyn Holash; Emma Lees; Lorena Taricani
Journal:  Mol Cancer Res       Date:  2014-09-17       Impact factor: 5.852

5.  Base excision repair defects invoke hypersensitivity to PARP inhibition.

Authors:  Julie K Horton; Donna F Stefanick; Rajendra Prasad; Natalie R Gassman; Padmini S Kedar; Samuel H Wilson
Journal:  Mol Cancer Res       Date:  2014-04-25       Impact factor: 5.852

6.  Poly(ADP-ribose) polymerase (PARP-1) has a controlling role in homologous recombination.

Authors:  Niklas Schultz; Elena Lopez; Nasrollah Saleh-Gohari; Thomas Helleday
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

7.  Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors.

Authors:  Todd A Hopkins; Yan Shi; Luis E Rodriguez; Larry R Solomon; Cherrie K Donawho; Enrico L DiGiammarino; Sanjay C Panchal; Julie L Wilsbacher; Wenqing Gao; Amanda M Olson; DeAnne F Stolarik; Donald J Osterling; Eric F Johnson; David Maag
Journal:  Mol Cancer Res       Date:  2015-07-27       Impact factor: 5.852

8.  Hypoxia provokes base excision repair changes and a repair-deficient, mutator phenotype in colorectal cancer cells.

Authors:  Norman Chan; Mohsin Ali; Gordon P McCallum; Ramya Kumareswaran; Marianne Koritzinsky; Bradly G Wouters; Peter G Wells; Steven Gallinger; Robert G Bristow
Journal:  Mol Cancer Res       Date:  2014-07-16       Impact factor: 5.852

Review 9.  Transcriptional roles of PARP1 in cancer.

Authors:  Matthew J Schiewer; Karen E Knudsen
Journal:  Mol Cancer Res       Date:  2014-06-10       Impact factor: 5.852

10.  Oxidative Stress-Induced Protein Damage Inhibits DNA Repair and Determines Mutation Risk and Therapeutic Efficacy.

Authors:  Elizabeth McAdam; Reto Brem; Peter Karran
Journal:  Mol Cancer Res       Date:  2016-04-22       Impact factor: 5.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.